Glaukos Corporation Announces Proposed Private Offering of $200 Million of Convertible Senior Notes
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS) (the “Company” or “Glaukos”), an ophthalmic medical technology and pharmaceutical company focused on…